Skip to main content

Advertisement

Table 1 Patient characteristics and laboratory findings at hospitalization

From: Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%

  Survivor group (n = 189) cardiac death group (n = 9) p-value*
Age (years) 65 ± 12 75 ± 12 < 0.01
Male, n (%) 156 (82.5) 8 (88.9) NS
Body mass index (kg/m2) 24.3 ± 3.3 22.4 ± 2.4 NS
Diabetes mellitus, n (%) 34 (18.0) 3 (33.3) NS
Dyslipidemia, n (%) 152 (80.4) 7 (77.8) NS
Hypertension, n (%) 103 (54.5) 5 (55.6) NS
Current smoker, n (%) 63 (33.3) 1 (11.1) NS
Family history of CAD, n (%) 58 (30.7) 1 (11.1) NS
Atrial fibrillation, n (%) 18 (9.5) 2 (22.2) NS
History of revascularization
 PCI, n (%) 31 (16.4) 1 (11.1) NS
 CABG, n (%) 7 (3.7) 0 (0.0) NS
Systolic blood pressure (mmHg) 139 ± 26 139 ± 36 NS
Diastolic blood pressure (mmHg) 79 ± 19 79 ± 24 NS
Heart rate (/min) 77 ± 17 88 ± 24 NS
LVEF (%) 56.6 ± 11.7 47.7 ± 14.0 0.03
Total cholesterol (mg/dl) 187 ± 43 168 ± 43 NS
Triglycerides (mg/dl) 137 ± 95 108 ± 33 NS
HDL-cholesterol (mg/dl) 46 ± 12 41 ± 15 NS
LDL-cholesterol (mg/dl) 115 ± 39 105 ± 28 NS
eGFR (ml/min/1.73 m2) 81.3 ± 20.4 68.1 ± 17.2 NS
Brain natriuretic peptide (pg/ml) 151 ± 345 597 ± 882 0.03
Albumin (g/dl) 4.0 ± 0.5 3.6 ± 0.7 0.01
Hemoglobin (g/dl) 14.5 ± 1.7 13.0 ± 2.3 0.01
Hemoglobin A1c (%) 5.8 ± 0.5 6.2 ± 0.6 0.02
1,5-AG (µg/ml) 19.2 ± 7.7 12.3 ± 5.3 < 0.01
  1. Data are presented as mean ± standard deviation, or number (percentage)
  2. CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, LVEF left ventricular ejection fraction, HDL high-density lipoprotein, LDL low-density lipoprotein, eGFR estimated glomerular filtration rate, 1,5-AG 1,5-anhydroglucitol
  3. * Comparisons between the survivor and the cardiac death groups